BoneSource receives 510(k) clearance
This article was originally published in Clinica
Executive Summary
Osteogenics' BoneSource hydroxyapatite cement has received 510(k) clearance from the US FDA to repair certain cranial defects. A multicentre study in the US of the calcium phosphate-based bone substitute was conducted on more than 100 patients showing good repair results after a minimum of two years follow-up (see Clinica No 695, pp 18 & 19).